Efficacy and Safety of Tenofovir DF/Atazanavir Enhanced With Low Dose of Ritonavir in HIV-Infected Patients

NCT00122577 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

50

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Tenofovir
DRUG: Atazanavir
DRUG: Ritonavir

Sponsor

French National Agency for Research on AIDS and Viral Hepatitis

Collaborators

[object Object]
[object Object]